Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients’ perspectives*
Lido
6003
Vezesque se leu este artigo
2772
Total PDF
3231
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 29 | 14 | 43 |
| 2025 5 | 141 | 72 | 213 |
| 2025 4 | 136 | 40 | 176 |
| 2025 3 | 141 | 53 | 194 |
| 2025 2 | 109 | 58 | 167 |
| 2025 1 | 94 | 45 | 139 |
| 2024 12 | 77 | 53 | 130 |
| 2024 11 | 94 | 45 | 139 |
| 2024 10 | 86 | 66 | 152 |
| 2024 9 | 103 | 86 | 189 |
| 2024 8 | 104 | 96 | 200 |
| 2024 7 | 102 | 104 | 206 |
| 2024 6 | 93 | 59 | 152 |
| 2024 5 | 53 | 54 | 107 |
| 2024 4 | 73 | 66 | 139 |
| 2024 3 | 66 | 52 | 118 |
| 2024 2 | 142 | 75 | 217 |
| 2024 1 | 63 | 40 | 103 |
| 2023 12 | 44 | 61 | 105 |
| 2023 11 | 49 | 74 | 123 |
| 2023 10 | 55 | 55 | 110 |
| 2023 9 | 62 | 61 | 123 |
| 2023 8 | 40 | 30 | 70 |
| 2023 7 | 37 | 26 | 63 |
| 2023 6 | 52 | 39 | 91 |
| 2023 5 | 59 | 13 | 72 |
| 2023 4 | 42 | 18 | 60 |
| 2023 3 | 58 | 39 | 97 |
| 2023 2 | 39 | 33 | 72 |
| 2023 1 | 38 | 42 | 80 |
| 2022 12 | 51 | 32 | 83 |
| 2022 11 | 72 | 45 | 117 |
| 2022 10 | 71 | 49 | 120 |
| 2022 9 | 46 | 43 | 89 |
| 2022 8 | 36 | 35 | 71 |
| 2022 7 | 32 | 70 | 102 |
| 2022 6 | 30 | 47 | 77 |
| 2022 5 | 23 | 54 | 77 |
| 2022 4 | 26 | 51 | 77 |
| 2022 3 | 35 | 63 | 98 |
| 2022 2 | 28 | 33 | 61 |
| 2021 1 | 64 | 47 | 111 |
| 2021 12 | 38 | 54 | 92 |
| 2021 11 | 40 | 57 | 97 |
| 2021 10 | 44 | 72 | 116 |
| 2021 9 | 32 | 44 | 76 |
| 2021 8 | 30 | 44 | 74 |
| 2021 7 | 35 | 40 | 75 |
| 2021 6 | 30 | 52 | 82 |
| 2021 5 | 34 | 58 | 92 |
| 2021 4 | 81 | 136 | 217 |
| 2021 3 | 24 | 43 | 67 |
| 2021 2 | 19 | 13 | 32 |
| 2020 1 | 19 | 15 | 34 |
| 2020 12 | 10 | 6 | 16 |
Mostrar tudo
